We are live on
!
Find out more
IP
Intellectus Partners Portfolio holdings
AUM
$578M
Turnover
15.36%
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$286M
AUM Growth
+$12.2M
(+4.4%)
Cap. Flow
+$9.03M
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
644
New
52
Increased
128
Reduced
112
Closed
63
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
1
year
Top 20 Avg Time Held Equity + Options
1.1
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.54M |
| 2 |
Tesla
TSLA
|
+$1.91M |
| 3 |
Caterpillar
CAT
|
+$1.8M |
| 4 |
Varonis Systems
VRNS
|
+$1.09M |
| 5 |
Micron Technology
MU
|
+$842K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.07M |
| 2 |
Accenture
ACN
|
+$1.02M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$838K |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$617K |
| 5 |
General Mills
GIS
|
+$571K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.33% |
| 2 | Communication Services | 14.54% |
| 3 | Technology | 14.07% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Healthcare | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CBB
551
DELISTED
Cincinnati Bell Inc.
CBB
| $3K | ﹤0.01% |
217
| – | – |
2016 Q4
7 quarters
|
|
|
IMDZ
552
DELISTED
Immune Design Corp.
IMDZ
| $3K | ﹤0.01% |
1,000
| – | – |
2018 Q1
2 quarters
|
|
553
Analog Devices
ADI
$196B
| $2K | ﹤0.01% |
20
| – | – |
2017 Q1
6 quarters
|
|
554
Celldex Therapeutics
CLDX
$2.27B
| $2K | ﹤0.01% |
267
| – | – |
2016 Q4
7 quarters
|
|
555
3D Systems Corp
DDD
$492M
| $2K | ﹤0.01% |
100
| – | – |
2016 Q4
7 quarters
|
|
556
Flotek Industries
FTK
$896M
| $2K | ﹤0.01% |
167
| – | – |
2016 Q4
7 quarters
|
|
557
Invitation Homes
INVH
$15.8B
| $2K | ﹤0.01% |
102
| – | – |
2017 Q4
3 quarters
|
|
558
Keurig Dr Pepper
KDP
$46.5B
| $2K | ﹤0.01% |
107
-56
| -34% | -$1.77K |
2017 Q2
5 quarters
|
|
559
DELISTED
Redfin
RDFN
| $2K | ﹤0.01% |
88
| – | – |
2018 Q2
1 quarter
|
|
560
Unum
UNM
$14.6B
| $2K | ﹤0.01% |
54
| – | – |
2016 Q4
7 quarters
|
|
|
IMNP
561
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $2K | ﹤0.01% |
31,082
| – | – |
2018 Q1
2 quarters
|
|
562
Codexis
CDXS
$149M
| $1K | ﹤0.01% |
74
| – | – |
2016 Q4
7 quarters
|
|
563
PUT
Gyre Therapeutics
GYRE
$679M
| $1K | ﹤0.01% |
+9
| New | +$713 |
2018 Q3
0 quarters
|
|
564
Lumentum
LITE
$78.8B
| $1K | ﹤0.01% |
25
| – | – |
2016 Q4
7 quarters
|
|
565
Theriva Biologics
TOVX
$9.73M
| $1K | ﹤0.01% |
1
| – | – |
2016 Q4
7 quarters
|
|
566
Viavi Solutions
VIAV
$9.05B
| $1K | ﹤0.01% |
125
| – | – |
2016 Q4
7 quarters
|
|
|
NMTR
567
DELISTED
9 Meters Biopharma
NMTR
| $1K | ﹤0.01% |
5
| – | – |
2018 Q1
2 quarters
|
|
|
VSM
568
DELISTED
Versum Materials, Inc.
VSM
| $1K | ﹤0.01% |
16
| – | – |
2016 Q4
7 quarters
|
|
569
Alcoa
AA
$10.7B
| – | – |
-263
| Closed | -$12K | – |
|
570
Advance Auto Parts
AAP
$2.65B
| – | – |
-2,959
| Closed | -$455K | – |
|
|
571
Accenture
ACN
$138B
| – | – |
-6,113
| Closed | -$1.02M | – |
|
|
572
iShares Core US Aggregate Bond ETF
AGG
$138B
| – | – |
-7,896
| Closed | -$838K | – |
|
573
Blackrock
BLK
$174B
| – | – |
-1
| Closed | – | – |
|
574
Vanguard Total Bond Market
BND
$163B
| – | – |
-854
| Closed | -$68K | – |
|
575
Berkshire Hathaway Class A
BRK.A
$1.13T
| – | – |
-800
| Closed | -$102K | – |
|
Similar funds
AFGAS
AHL
CTAF
HIM
SSP
CA
PWM
MFS
Intellectus Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Intellectus Partners held 644 positions worth $286M, up 4.4% from $274M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Intellectus Partners deployed $9.03M of net new capital in Q3 2018, opening 52 new positions and adding to 128 existing holdings. Its largest new stake was OptimizeRx: 65,000 shares worth $1.17M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 28% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was IBM, an estimated $1.07M trimmed.
- Intellectus Partners's largest Q3 2018 buy was OptimizeRx: 65,000 shares worth $1.17M.
- Intellectus Partners added most to Meta Platforms (Facebook) in Q3 2018, an estimated $2.54M increase.
- Intellectus Partners's biggest Q3 2018 reduction was IBM, cutting an estimated $1.07M.
- Intellectus Partners fully exited Accenture in Q3 2018, selling an estimated $1.02M.
- Intellectus Partners's ten largest holdings make up 25% of its $286M portfolio in Q3 2018.
- Intellectus Partners opened 52 new positions and closed 63 in Q3 2018.
- Intellectus Partners's portfolio value rose 4.4% quarter-over-quarter to $286M.
Based on Intellectus Partners's 13F filing for Q3 2018, filed 15 Nov 2018.